Recovery With Virtual Reality for Stress and Pain (ReVRS)
Recovery With Virtual Reality for Stress & Pain (ReVRS)
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Detaljert beskrivelse
Preoperative anxiety and postoperative pain may negatively affect patients' recovery after surgery. Virtual reality may provide a non-pharmacological method of distraction and relaxation, but its effect on perioperative anxiety and early postoperative recovery requires further evaluation.
This prospective, randomized, parallel-group controlled trial will include approximately 140 adults undergoing elective gynecological surgery. After providing informed consent, participants will be randomized in a 1:1 ratio to one of two groups:
- Virtual reality plus usual perioperative care.
- Usual perioperative care alone.
Participants assigned to the intervention group will use a virtual reality headset for approximately 10-20 minutes before surgery and view an immersive relaxation environment. The intervention may be discontinued at any time if the participant experiences discomfort, nausea, dizziness, anxiety, or other adverse symptoms.
The primary outcome is the change in preoperative anxiety from immediately before to immediately after the intervention period, assessed using the State-Trait Anxiety Inventory-State scale and/or a numerical rating scale for anxiety.
Secondary outcomes include quality of recovery measured with the Quality of Recovery-15 questionnaire, postoperative pain measured using a numerical rating scale, opioid consumption expressed as morphine milligram equivalents, postoperative nausea and vomiting, time spent in the postoperative care unit, and other indicators of early postoperative recovery. Follow-up assessments are planned at approximately 24 and 72 hours and on postoperative days 7 and 10.
The study will examine whether preoperative virtual reality reduces anxiety and whether any reduction is associated with improved postoperative recovery and reduced symptom burden.
Studietype
Studietype
Registrering (Antatt)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Pether Jildenstål, Professor
- Telefonnummer: +46 76-026 66 58
- E-post: pether.jildenstal@med.lu.se
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Adults aged 18 years or older.
- Scheduled to undergo elective gynecological surgery according to the study protocol at a participating center where virtual reality can be provided.
- Able and willing to provide informed consent for study participation, 1:1 randomization, and use of virtual reality.
Exclusion Criteria:
- Increased risk of adverse effects related to virtual reality, including pronounced motion sickness, claustrophobia, or photosensitive epilepsy.
- Active substance use disorder or active misuse of alcohol or illicit drugs.
- Severe chronic pain and/or regular preoperative opioid treatment, as defined in the study protocol.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Eksperimentell: Virtual Reality Plus Usual Care
Participants receive a preoperative virtual reality session in addition to usual perioperative care.
The session lasts approximately 10-20 minutes and is delivered in the waiting or preoperative area using calm nature or relaxation scenes intended to promote comfort and distraction.
|
A single preoperative virtual reality session lasting approximately 10-20 minutes, administered in the waiting or preoperative area.
Participants view calm nature, relaxation, or guided-breathing scenes using a virtual reality headset.
The intervention is intended to provide relaxation, comfort, and distraction before surgery.
|
|
Aktiv komparator: Usual Care
Participants receive usual perioperative care without virtual reality during the corresponding preoperative period.
|
Participants receive standard perioperative care according to local clinical routines.
No preoperative virtual reality session is provided during the corresponding intervention period.
|
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Quality of Postoperative Recovery Measured With QoR-15
Tidsramme: 24 hours after surgery
|
Postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15).
The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
|
24 hours after surgery
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Preoperative Anxiety
Tidsramme: From immediately before to immediately after the intervention, approximately 10-20 minutes
|
Anxiety will be assessed before and after the preoperative intervention period using the anxiety measure specified in the study protocol.
Higher scores indicate greater anxiety.
|
From immediately before to immediately after the intervention, approximately 10-20 minutes
|
|
Postoperative Pain Intensity
Tidsramme: Up to 72 hours after surgery
|
Postoperative pain will be assessed using a numerical rating scale from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
|
Up to 72 hours after surgery
|
|
Postoperative Opioid Consumption
Tidsramme: During the first 24 hours after surgery
|
Total postoperative opioid consumption will be calculated and converted to intravenous morphine milligram equivalents.
|
During the first 24 hours after surgery
|
|
Incidence of Postoperative Nausea and Vomiting
Tidsramme: During the first 24 hours after surgery
|
Number and proportion of participants experiencing nausea, vomiting, or both during the postoperative period.
|
During the first 24 hours after surgery
|
|
Duration of Stay in the Post-Anesthesia Care Unit
Tidsramme: On the day of surgery
|
Time from admission to discharge from the post-anesthesia care unit.
|
On the day of surgery
|
|
Quality of Recovery at 72 Hours Measured With QoR-15
Tidsramme: 72 hours after surgery
|
Quality of postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15).
The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
|
72 hours after surgery
|
|
Quality of Recovery on Postoperative Day 7 Measured With QoR-15
Tidsramme: 7 days after surgery
|
Quality of postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15).
The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
|
7 days after surgery
|
|
Quality of Recovery on Postoperative Day 10 Measured With QoR-15
Tidsramme: 10 days after surgery
|
Quality of postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15).
The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
|
10 days after surgery
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
Andre studie-ID-numre
- 2026-03077-01 (Annen identifikator: Swedish Ethical Review Authority)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .